Arm Motor Rehabilitation, Entertainment and Cognition System for the Elderly
NCT ID: NCT04252170
Last Updated: 2020-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2 participants
INTERVENTIONAL
2018-09-15
2019-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Arm Motor Rehabilitation, Entertainment and Cognition System for the Elderly (Clinical Trial)
NCT04724954
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
NCT03401762
Robotically Augmented Mental Practice
NCT04962698
A Novel Brain Stimulation for Bimanual Motor Function and Control in Chronic Stroke
NCT05381740
Motor Imagery and Motor Execution Based BCI in Stroke
NCT05634616
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Specific aims are:
* BAC technology acceptance;
* improvement in motor function for the upper extremity;
* strengthening of shoulder and fingers;
* increased active (self initiated) range of motion for shoulder, arms and fingers;
* improved independence in activities of daily living;
* improvement in cognitive areas of memory, attention and decision making;
* improved mood (as in reduced depression severity);
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DEVICE_FEASIBILITY
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Feasibility study, Stroke Survivors
BAC feasibility study at PowerBack, Piscataway NJ, with stroke patients.
Rehabilitation Therapy, Experimental on the BrightArm Compact device
Experimental group will receive VR game-based rehabilitation therapy through Bright Cloud's proprietary device, called BrightArm Compact (BAC). An Occupational Therapist will assist as needed.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rehabilitation Therapy, Experimental on the BrightArm Compact device
Experimental group will receive VR game-based rehabilitation therapy through Bright Cloud's proprietary device, called BrightArm Compact (BAC). An Occupational Therapist will assist as needed.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of first-time CVA that occurred more than 5 days prior and less than 21 days prior
* English speakers;
* UE unilateral or bilateral involvement (from new bilateral CVA)
* motor involvement (FMA score 20 to 45);
* ability to actively move UE more than 10 degrees for shoulder and elbow flexion/extension;
* ability to actively extend fingers at least 5 degrees
* cognitive skills to participate (Montreal Cognitive Assessment (MoCA) \[Nasreddine et al 2005\] score 10-30).
* Subjects may have normal cognition, MCI or dementia
Exclusion Criteria
* previous stroke
* Stroke that occurred more than 20 days prior to enrollment
* Inability to actively extend fingers at least 5 degrees;
* Fugl-Meyer scores of 19 or less;
* severe visual neglect or legally blind
* severe hearing loss or deafness
* receptive aphasia or severe expressive aphasia;
* severe spasticity (Modified Ashworth Scale 4/4)
* contractures of the upper limb joints
* uncontrolled hypertension (\>190/100 mmHg)
* severe cognitive impairment determined by Montreal Cognitive Assessment (MoCA) \[Nasreddine et al, 2005\] test of 9 and below;
* No chemodenervation or nerve block to upper limb involved during the experimental period (e.g., botulinum toxin injection)
* inability to speak English;
* a history of violence or drug abuse;
* paranoia and psychotic behavior;
* inability participate in the neuropsychological pre-study assessment for reliable scores (e.g., cognitive impairment, communication disorders).
50 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
Genesis HealthCare System
OTHER
Bright Cloud International Corp
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Nam H. Kim
Director of Engineering
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Grigore C Burdea, Ph.D.
Role: STUDY_CHAIR
BRIGHT CLOUD INTL CORP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
PowerBack Rehabilitation
Piscataway, New Jersey, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Burdea G, Kim N, Polistico K, Kadaru A, Grampurohit N, Hundal J, Pollack S. Robotic Table and Serious Games for Integrative Rehabilitation in the Early Poststroke Phase: Two Case Reports. JMIR Rehabil Assist Technol. 2022 Apr 13;9(2):e26990. doi: 10.2196/26990.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Document Type: Study Protocol
Related Links
Access external resources that provide additional context or updates about the study.
BCI's corporate site
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BCI-10-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.